TREM2 and cholesteatoma: TREM2 amplifies the inflammatory response of the TLR4 signaling pathway, promoting the secretion of MMP-2 and MMP-8 and the excessive activation of osteoclasts, thereby facilitating bone destruction induced by acquired cholesteatoma (44).